Data shows treatment can lead to ‘brain shrinkage’ By Maryanne Demasi, PhD | January 9, 2023 The US Food and Drug Administration (FDA) has granted an accelerated approval of a new treatment for Alzheimer’s disease, which aims to clear toxic amyloid protein build-up in the brain. At a cost of $26,500 per year in the US (not covered by […]
Source